Latest Period
Q2 2026
Security Snapshot
Ernexa Therapeutics Inc. - COM (ERNA) Institutional Ownership
CUSIP: 114082407
13F Institutional Holders and Ownership History for Q2 2026
Institutions Reporting
9
Shares (Excl. Options)
35,525
Price
$6.65
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COM
- Symbol
- ERNA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 35,525
- Total 13F value
- $236,242
- Portfolio coverage rank
- 0%
- Share change
- +35,524
- Value change
- +$236,235
- Number of holders
- 9
- SEC-reported price per share
- $7.12
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ERNA - Ernexa Therapeutics Inc. - COM is tracked under CUSIP 114082407.
- 9 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Latest quarter on this page is Q2 2026.
- Additional quarter-over-quarter change detail appears as history expands.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 9 institutions filings for Q2 2026.
Security key
114082407
Latest holder period
Q2 2026
13F holders
9
13D/G owners
0
CIK / CUSIP context first
Open Q2 2026 holders
ERNA full holder history
Ernexa Therapeutics Inc. SEC filings
Ernexa Therapeutics Inc. company facts
Ernexa Therapeutics Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 114082407:
As of 30 Jun 2026, 9 institutional investors reported holding 35,525 shares of Ernexa Therapeutics Inc. - COM (ERNA).
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
1
Latest
Q2 2026
Rows shown
1-1 of 1
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 35,525 | $236,242 | +$236,235 | $6.65 | 9 |